Investigation on influence of Wurster coating process parameters for the development of delayed release minitablets of Naproxen

References

• Politis SN, Rekkas DM. Pelletization processes for pharmaceutical applications: a patent review. Ddf. 2011;5:61–78.
   Google Scholar
• Alhusban F, Perrie Y, Mohammed AR. Formulation of multiparticulate systems as lyophilised orally disintegrating tablets. Eur J Pharm Biopharm. 2011;79:627–634.
   PubMed Web of Science ®Google Scholar
• Goole J, Van Gansbeke B, Pilcer G, et al. Pharmacoscintigraphic and pharmacokinetic evaluation on healthy human volunteers of sustained-release floating minitablets containing levodopa and carbidopa. Int J Pharm. 2008;364:54–63.
   PubMed Web of Science ®Google Scholar
• Kristensen J, Schaefer T, Kleinebudde P. Development of fast-disintegrating pellets in a rotary processor. Drug Dev Ind Pharm. 2002;28:1201–1212.
   PubMed Web of Science ®Google Scholar
• Nikowitz K, Kása P, Pintye-Hódi K, et al. Study of the preparation of a multiparticulate drug delivery system with a layering technique. Powder Technol. 2011;205:155–159.
   Web of Science ®Google Scholar
• Gaber DM, Nafee N, Abdallah OY. Mini-tablets versus pellets as promising multiparticulate modified release delivery systems for highly soluble drugs. Int J Pharm. 2015;488:86–94.
   PubMed Web of Science ®Google Scholar
• Cerpnjak K, Zvonar Pobirk A, Vrecer F, et al. Tablets and minitablets prepared from spray-dried SMEDDS containing naproxen. Int J Pharm. 2015;495:336–346.
   PubMed Web of Science ®Google Scholar
• Ishida M, Abe K, Hashizume M, et al. A novel approach to sustained pseudoephedrine release: differentially coated mini-tablets in HPMC capsules. Int J Pharm. 2008;359:46–52.
   PubMed Web of Science ®Google Scholar
• Vemula SK. Formulation and pharmacokinetics of colon-specific double-compression coated mini-tablets: Chronopharmaceutical delivery of ketorolac tromethamine. Int J Pharm. 2015;491:35–41.
   PubMed Web of Science ®Google Scholar
• Rouge N, Leroux J, Cole E, et al. Prevention of the sticking tendency of floating minitablets filled into hard gelatin capsules. Eur J Pharm Biopharm. 1997;43:165–171.
   Web of Science ®Google Scholar
• Adam AK, Zimmer C, Rauscher S, et al. Multiple-unit orodispersible mini-tablets. Int J Pharm. 2016;511:1128.
   Web of Science ®Google Scholar
• Biyyala V, Rumondor A, Thompson K, et al. Novel solid oral dosage form in pediatric populations – Emphasis on minitablets. Int J Pharm. 2016;511:1145.
   Web of Science ®Google Scholar
• Hayakawa Y, Uchida S, Namiki N. Evaluation of the ease of taking mini-tablets compared with other tablet formulations in healthy volunteers. Eur J Pharm Sci. 2016;84:157–161.
   PubMed Web of Science ®Google Scholar
• Magdalena C, Hanna K, Anna M, et al. Development of matrix type and coated prolonged release minitablets with carbamazepine. Int J Pharm. 2016;511:1132.
   Web of Science ®Google Scholar
• Pinto JT, Brachkova MI, Fernandes AI, et al. Evaluation of the ability of powdered milk to produce minitablets containing paracetamol for the paediatric population. Chem Eng Res Des. 2016;110:171–182.
   Web of Science ®Google Scholar
• Rao KV, Venkatchalam VV. Mucoadhesive biphasic minitablets of cefuroxime axetil: Formulation development, characterization and in vivo bioavailability study. J Drug Deliv Sci Technol. 2016;35:260–271.
   Web of Science ®Google Scholar
• Tissen C, Woertz K, Breitkreutz J, et al. Development of mini-tablets with 1mm and 2mm diameter. Int J Pharm. 2011;416:164–170.
   PubMed Web of Science ®Google Scholar
• Van Riet-Nales DA, Ferreira JA, Schobben AF, et al. Methods of administering oral formulations and child acceptability. Int J Pharm. 2015;491:261–267.
   PubMed Web of Science ®Google Scholar
• Camblin M, Berger B, Haschke M, et al. CombiCap: A novel drug formulation for the basel phenotyping cocktail. Int J Pharm. 2016;512:253–261.
   PubMed Web of Science ®Google Scholar
• Hadi MA, Raghavendra Rao NG, Srinivasa Rao A. Formulation and evaluation of ileo-colonic targeted matrix-mini-tablets of Naproxen for chronotherapeutic treatment of rheumatoid arthritis. Saudi Pharm J. 2016;24:64–73.
   PubMed Web of Science ®Google Scholar
• Liu F, Ghaffur A, Bains J, et al. Acceptability of oral solid medicines in older adults with and without dysphagia: a nested pilot validation questionnaire based observational study. Int J Pharm. 2016;512:374–381.
   PubMed Web of Science ®Google Scholar
• Porter S, Sackett G, Liu L. Development, optimization and scale-up of process parameters: pan coating. Zhang G, Qiu Y, editors. Developing solid oral dosage forms. San Diego: Academic Press; 2009.
   Google Scholar
• Jones D. Development, optimization and scale-up of process parameters: wurster coating. Zhang G, Qiu Y, editors. Developing solid oral dosage forms. San Diego: Academic Press; 2009.
   Google Scholar
• Hampel N, Bück A, Peglow M, et al. Continuous pellet coating in a Wurster fluidized bed process. Chem Eng Sci. 2013;86:87–98.
   Web of Science ®Google Scholar
• Olsen KW. Fluid bed equipment. Ghebre-Sellassie I, editor. Pharmaceutical pelletization technology. New York: Marcel Dekker; 2014.
   Google Scholar
• Cole GC. Coating pans and coating columns. Cole G, editor. Pharmaceutical coating technology. New York: Marcel Dekker; 2008.
   Google Scholar
• Suhrenbrock L, Radtke G, Knop K, et al. Pellet layering: scale-up considerations using different kinds of processing equipment. Drug Dev Ind Pharm. 2012;38:1494–1503.
   PubMed Web of Science ®Google Scholar
• Christensen FN, Bertelsen P. Qualitative description of the Wurster-based fluid bed coating process. Drug Dev Ind Pharm. 1997;23:451–463.
   Web of Science ®Google Scholar
• Jangam SV, Mujumdar AS, Thorat BN. Design of an efficient gas distribution system for a fluid bed dryer. Drying Technol. 2009;27:1217–1228.
   Web of Science ®Google Scholar
• Geldart D. Types of gas fluidization. Powder Technol. 1973;7:285–292.
   Web of Science ®Google Scholar
• Mora CP, Martínez F. Solubility of naproxen in several organic solvents at different temperatures. Fluid Phase Equilib. 2007;255:70–77.
   Web of Science ®Google Scholar
• Shah N, Mehta T, Gohel M. Formulation and optimization of multiparticulate drug delivery system approach for high drug loading. AAPS PharmSciTech 2017;18:2157–2167.
   PubMed Web of Science ®Google Scholar
• Czajkowska M, Sznitowska M, Kleinebudde P. Determination of coating thickness of minitablets and pellets by dynamic image analysis. Int J Pharm. 2015;495:347–353.
   PubMed Web of Science ®Google Scholar
• Omari DM. Formulation and Invitro/Invivo evaluation of esomeprazole enteric coated minitablets. J Drug Deliv Sci Technol. 2017;39:156–165.
   Web of Science ®Google Scholar
• Ocana J, Frutos G, Sanchez P. Using the similarity factor f2 in practice: A critical revision and suggestions for its standard error estimation. Chemometr Intell Lab Syst. 2009;99:49–56.
   Web of Science ®Google Scholar
• Peh KK, Wong CF. Application of similarity factor in development of controlled-release diltiazem tablet. Drug Dev Ind Pharm. 2000;26:723–730.
   PubMed Web of Science ®Google Scholar
• Khuri AI, Mukhopadhyay S. Response surface methodology. Wires Comp Stat. 2010;2:128–149.
   Google Scholar
• Skalsky B, Petereit H-U. Aqueous polymeric coatings for pharmaceutical dosage forms. Florida: CRC Press; 2008. Chapter 9, chemistry and application properties of polymethacrylate systems.
   Google Scholar